Literature DB >> 177052

The content of prostaglandin E and prostaglandin F2alpha in the exudate of carrageenin granuloma of rats.

K Ohuchi, H Sato, S Tsurufuji.   

Abstract

1. Granuloma was made by the subcutaneous injection of 2% carrageenin solution on the dorsum of male rats. Eight, 16, 24 and 72 h after the injection. the exudate from each rat granuloma was withdrawn and extracted for rpstaglandins. 2. Extracted prostaglandins were separated prostaglandin E and prostaglandin F group by silicic acid mini-column chromatography. Then the amount of prostaglandin E and prostaglandin F2alpha were determined by the radioimmunoassay method. 3. The levels of prostaglandin E in the granuloma exudates were 4.6 ng/ml at 8 h after the carrageenin injection, then decreased 3.6 ng/ml and to 1.1 ng/ml at 16 h and 24 h, respectively. Seventy-two h after the injection, prostaglandin E level was increased to 8.1 ng/ml. 4. The levels of prostaglandin F2alpha in the exudate were as follows: At 8 h after the carrageenin injection, the level was 9.4 ng/ml, then decreased to 1.3 ng/ml and to 0.8 ng/ml at 16 h and 24 h, respectively. Seventy-two h after the carrageenin injection, it was again elevated to 4.7 ng/ml. 5. The exudate of granuloma, 24 and 72 h after the carrageenin injection, was incubated with [3H]prostaglandin E1 at 37 degrees C for 30 min. Then the acidic ether extract was subjected to reversed phase partition chromatography. It was found that the exudate of 24 h and 72 h granuloma had little activity of prostaglandin 15alpha-hydroxy dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 177052     DOI: 10.1016/0005-2760(76)90033-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Serum IgG, IgM and slow alpha-globulin levels in carrageenan-treated rats.

Authors:  E F Fowler; A W Thomson
Journal:  Br J Exp Pathol       Date:  1979-08

2.  Factors responsible for dermally induced epidermal hyperplasia.

Authors:  A J Francis; R Marks
Journal:  Arch Dermatol Res       Date:  1977-05-27       Impact factor: 3.017

3.  In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin.

Authors:  D M Dirig; T L Yaksh
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

4.  A possible role of prostaglandins and bradykinin as a trigger of exudation in carrageenin-induced rat pleurisy.

Authors:  M Katori; K Ikeda; Y Harada; Y Uchida; K Tanaka; S Oh-Ishi
Journal:  Agents Actions       Date:  1978-01

5.  Direct activation of rat spinal dorsal horn neurons by prostaglandin E2.

Authors:  H Baba; T Kohno; K A Moore; C J Woolf
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

6.  Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties.

Authors:  José Christian Machado Ximenes; Danilo de Oliveira Gonçalves; Rafaelly Maria Pinheiro Siqueira; Kelly Rose Tavares Neves; Gilberto Santos Cerqueira; Alyne Oliveira Correia; Francisco Hélder Cavalcante Félix; Luzia Kalyne Almeida Moreira Leal; Gerly Anne de Castro Brito; Maria da Graça Naffah-Mazzacorati; Glauce Socorro de Barros Viana
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-14       Impact factor: 3.000

7.  Role of lipoxygenase products in murine pulmonary granuloma formation.

Authors:  S L Kunkel; S W Chensue; C Mouton; G I Higashi
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

8.  Development of enhanced blood flow responses to prostaglandin E1 in carrageenan-induced granulation tissue.

Authors:  M J Parnham; L D de Leve; P R Saxena
Journal:  Agents Actions       Date:  1979-12

9.  Suppression of nephrotoxic serum nephritis in rats by prostaglandin E1.

Authors:  S L Kunkel; M Zanetti; C Sapin
Journal:  Am J Pathol       Date:  1982-08       Impact factor: 4.307

10.  Time-dependent stimulatory and inhibitory effects of prostaglandin E1 on exudative and tissue components of granulomatous inflammation in rats.

Authors:  I L Bonta; M J Parnham
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.